Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2. Currently, several strategies are being pursued to...

Full description

Bibliographic Details

Published in:	Pathogens
Main Authors:	Edris Shirvani, Siba K. Samal
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Subjects:	SARS-CoV-2 COVID-19 coronavirus Newcastle disease virus (NDV) vaccine viral vector and viral respiratory infection
Online Access:	https://www.mdpi.com/2076-0817/9/8/619